$2.28T
Total marketcap
$126.02B
Total volume
BTC 49.82%     ETH 15.76%
Dominance

Sinopharm Group Co. Ltd. X2S1.F Stock

11.4 EUR {{ price }} -0.869569% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
7.22B EUR
LOW - HIGH [24H]
11.4 - 11.4 EUR
VOLUME [24H]
20 EUR
{{ volume }}
P/E Ratio
6.09
Earnings per share
1.87 EUR

Sinopharm Group Co. Ltd. Price Chart

Sinopharm Group Co. Ltd. X2S1.F Financial and Trading Overview

Sinopharm Group Co. Ltd. stock price 11.4 EUR
Previous Close 12.5 EUR
Open 12.6 EUR
Bid 12.6 EUR x N/A
Ask 13.1 EUR x N/A
Day's Range 12.5 - 12.5 EUR
52 Week Range 9 - 15.9 EUR
Volume 200 EUR
Avg. Volume 8 EUR
Market Cap 7.89B EUR
Beta (5Y Monthly) 0.78009
PE Ratio (TTM) 7.0391064
EPS (TTM) 1.87 EUR
Forward Dividend & Yield 0.52 (4.13%)
Ex-Dividend Date June 15, 2023
1y Target Est N/A

X2S1.F Valuation Measures

Enterprise Value 76.81B EUR
Trailing P/E 7.0391064
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.013835666
Price/Book (mrq) 0.11260557
Enterprise Value/Revenue 0.135
Enterprise Value/EBITDA 3.041

Trading Information

Sinopharm Group Co. Ltd. Stock Price History

Beta (5Y Monthly) 0.78009
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 15.9 EUR
52 Week Low 9 EUR
50-Day Moving Average 13.51 EUR
200-Day Moving Average 12.94 EUR

X2S1.F Share Statistics

Avg. Volume (3 month) 8 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 624.13M
Float 268.33M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.037%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.82
Trailing Annual Dividend Yield 6.56%
5 Year Average Dividend Yield N/A
Payout Ratio 0.2728
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 1.52%
Operating Margin (ttm) 4.03%
Gross Margin 8.48%
EBITDA Margin 4.43%

Management Effectiveness

Return on Assets (ttm) 3.77%
Return on Equity (ttm) 13.67%

Income Statement

Revenue (ttm) 570.07B EUR
Revenue Per Share (ttm) 912.34 EUR
Quarterly Revenue Growth (yoy) 14.00%
Gross Profit (ttm) 47.43B EUR
EBITDA 25.26B EUR
Net Income Avi to Common (ttm) 8.69B EUR
Diluted EPS (ttm) 1.79
Quarterly Earnings Growth (yoy) 11.40%

Balance Sheet

Total Cash (mrq) 47.2B EUR
Total Cash Per Share (mrq) 75.62 EUR
Total Debt (mrq) 72.81B EUR
Total Debt/Equity (mrq) 64.37 EUR
Current Ratio (mrq) 1.337
Book Value Per Share (mrq) 111.895

Cash Flow Statement

Operating Cash Flow (ttm) 16.76B EUR
Levered Free Cash Flow (ttm) 23.88B EUR

Profile of Sinopharm Group Co. Ltd.

Country Germany
State N/A
City Shanghai
Address Sinopharm Group Building
ZIP 200023
Phone 86 21 2305 2666
Website https://www.sinopharmgroup.com.cn
Industry Medical Distribution
Sector(s) Healthcare
Full Time Employees 114766

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Q&A For Sinopharm Group Co. Ltd. Stock

What is a current X2S1.F stock price?

Sinopharm Group Co. Ltd. X2S1.F stock price today per share is 11.4 EUR.

How to purchase Sinopharm Group Co. Ltd. stock?

You can buy X2S1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sinopharm Group Co. Ltd.?

The stock symbol or ticker of Sinopharm Group Co. Ltd. is X2S1.F.

Which industry does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. industry is Medical Distribution.

How many shares does Sinopharm Group Co. Ltd. have in circulation?

The max supply of Sinopharm Group Co. Ltd. shares is 632.97M.

What is Sinopharm Group Co. Ltd. Price to Earnings Ratio (PE Ratio)?

Sinopharm Group Co. Ltd. PE Ratio is 6.09625630 now.

What was Sinopharm Group Co. Ltd. earnings per share over the trailing 12 months (TTM)?

Sinopharm Group Co. Ltd. EPS is 1.87 EUR over the trailing 12 months.

Which sector does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. sector is Healthcare.